GT BIOPHARMA INC's ticker is GTBP and the CUSIP is 36254L209.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $0 | -100.0% | 2,436 | -36.2% | 0.00% | – |
| Q2 2023 | $2,000 | +100.0% | 3,819 | +52.3% | 0.00% | – |
| Q1 2023 | $1,000 | -99.6% | 2,508 | -99.1% | 0.00% | – |
| Q4 2022 | $250,000 | +8233.3% | 281,958 | +13534.3% | 0.00% | – |
| Q3 2022 | $3,000 | -50.0% | 2,068 | +5.6% | 0.00% | – |
| Q2 2022 | $6,000 | -33.3% | 1,958 | -35.8% | 0.00% | – |
| Q1 2022 | $9,000 | -55.0% | 3,049 | -52.2% | 0.00% | – |
| Q4 2021 | $20,000 | -28.6% | 6,377 | +54.3% | 0.00% | – |
| Q3 2021 | $28,000 | -49.1% | 4,134 | +15.2% | 0.00% | – |
| Q2 2021 | $55,000 | -67.1% | 3,590 | -85.4% | 0.00% | – |
| Q1 2021 | $167,000 | – | 24,542 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gordian Capital Singapore Pte Ltd | 35,000 | $107,000 | 0.08% |
| Crumly & Associates Inc. | 32,163 | $85,000 | 0.03% |
| Anson Funds Management LP | 43,692 | $133,000 | 0.01% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 23,106 | $70,000 | 0.01% |
| Investmark Advisory Group LLC | 1,450 | $4,000 | 0.00% |
| Welch Group, LLC | 10,000 | $31,000 | 0.00% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 28,860 | $88,000 | 0.00% |
| Compagnie Lombard Odier SCmA | 30,000 | $92,000 | 0.00% |
| BRIGHTON JONES LLC | 11,288 | $34,000 | 0.00% |
| TWO SIGMA ADVISERS, LP | 119,900 | $366,000 | 0.00% |